Table 2.
Days after RNA (DR) for SARS‐CoV‐2 | |||||
---|---|---|---|---|---|
All | 1–7 | 8–13 | 14–31 | ≥32 | |
No. samples | 218 | 86 | 22 | 59 | 51 |
No. positive for IgG (%) | 178 (82) | 78 (91) | 21 (96) | 51 (86) | 28 (55) |
No. positive for IgA (%) | 105 (48) | 65 (76) | 12 (55) | 27 (46) | 1 (2) |
All | Asymptomatic | Mild | Moderate | Severe | |
No. samples | 218 | 42 | 56 | 25 | 95 |
No. positive for IgG (%) | 178 (82) | 25 (60) | 34 (61) | 24 (96) | 95 (100) |
No. positive for IgA (%) | 105 (48) | 2 (5) | 8 (9) | 11 (44) | 84 (88) |
Note: Percentage of samples by days after RNA according to test result (one spot or more ≥70 Virachip® units for IgG and two spots or more for IgA).
Abbreviation: SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.